Indications
Zipradon is an atypical antipsychotic. In choosing among treatments, prescribers should be aware of Zipradon's capacity to prolong the QT interval and may consider the use of other drugs first. Zipradon capsules are indicated for the treatment of schizophrenia in adults, for acute treatment of manic or mixed episodes associated with bipolar I disorder in adults as monotherapy, and for maintenance treatment of bipolar I disorder in adults as an adjunct to lithium or valproate.
⚠️ Always consult a registered physician before taking any medicine.
Pharmacology
Ziprasidone's action in the listed indications is thought to result from a combination of antagonism at dopamine type 2 (D2) and serotonin type 2 (5HT2) receptors. The drug binds with relatively high affinity to dopamine D2 and D3 receptors, serotonin 5HT2A, 5HT2C, 5HT1A, and 5HT1D receptors, and α1-adrenergic receptors (Ki values of 4.8, 7.2, 0.4, 1.3, 3.4, 2, and 10 nM, respectively), and with moderate affinity to the histamine H1 receptor (Ki=47 nM). It acts as an antagonist at the D2, 5HT2A, and 5HT1D receptors, and as an agonist at the 5HT1A receptor. Ziprasidone also inhibits synaptic reuptake of serotonin and norepinephrine. It showed no appreciable affinity for the other receptor and binding sites tested, including the cholinergic muscarinic receptor (IC50 greater than 1 µM).
Dosage Reference
⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.
Side Effects & Interactions
Side Effects
No side-effect data recorded yet.